Core Insights - The stock price of biotech company Jiajie Ankang (2617.HK) has experienced unprecedented volatility since its listing in June, soaring from HKD 13.15 to HKD 679.5, before plummeting to HKD 149.9, reflecting a dramatic fluctuation of over 10 times in just 7 trading days, followed by a 78% drop in 4 days [2] Group 1 - The extreme market behavior highlights the risks inherent in the passive investment mechanisms of index funds [2] - Multiple ETFs tracking the National Index of Hong Kong Innovative Drugs were forced to buy at high prices due to component stock adjustments, drawing significant market attention [2] - This situation has sparked discussions among investors regarding the operational mechanisms of ETFs and raised questions about the rationality and transparency of related index compilation [2]
7天暴涨10倍，1小时蒸发1000亿！港股最疯剧本背后的真相
2 1 Shi Ji Jing Ji Bao Dao·2025-09-26 11:04